Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02506674

Ligand	Ligand name	Chain	PDB	Tanimoto
TY2	3-AMINO-L-TYROSINE	A,B	2VH3	0.7
413	(S)-[(R)-2-(4-BENZYLOXY-3-METHOXY-PHENYL)-2-(4-CARBAMIMIDOYL-PHENYLAMINO)-ACETYLAMINO]-PHENYL-ACETIC ACID	H,L	1W7X	0.72
413	(S)-[(R)-2-(4-BENZYLOXY-3-METHOXY-PHENYL)-2-(4-CARBAMIMIDOYL-PHENYLAMINO)-ACETYLAMINO]-PHENYL-ACETIC ACID	H	1W8B	0.72
2TY	2-HYDROXY-5-{[(1E)-2-PHENYLETHYLIDENE]AMINO}-L-TYROSINE	A,B	2CWV	0.7
ZYA	BENZOYL-TYROSINE-ALANINE-METHYL KETONE	A	1AIM	0.7
U04	({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER	A	4UPJ	0.72
CTZ	C2-HYDROXY-COELENTERAZINE	A	2HPS	0.73
CTZ	C2-HYDROXY-COELENTERAZINE	A	1EL4	0.73
A48	4-[(DIMESITYLBORYL)(2,2,2-TRIFLUOROETHYL)AMINO]PHENOL	A,B	2Q6J	0.72
CZM	'N,N'-BIS-(2-HYDROXY-3-METHYL-BENZYLIDENE)-BENZENE-1,2-DIAMINE'	A	1J3F	0.74
CZM	'N,N'-BIS-(2-HYDROXY-3-METHYL-BENZYLIDENE)-BENZENE-1,2-DIAMINE'	A	1UFJ	0.74
CZM	'N,N'-BIS-(2-HYDROXY-3-METHYL-BENZYLIDENE)-BENZENE-1,2-DIAMINE'	A	1V9Q	0.74
AEJ	(1S)-1-{4-[(9AR)-OCTAHYDRO-2H-PYRIDO[1,2-A]PYRAZIN-2-YL]PHENYL}-2-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLIN-6-OL	A,B,C,D	1XQC	0.73
C00	2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione	A	3BYX	0.71
C00	2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione	A	3BZ0	0.71
CZI	(2R)-8-BENZYL-2-HYDROPEROXY-6-(4-HYDROXYPHENYL)-2-(4-IODOBENZYL)-7,8-DIHYDROIMIDAZO[1,2-A]PYRAZIN-3(2H)-ONE	A,B	1UHI	0.72
421	6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER	A	1ZSK	0.74
R69	N-[4-({4-[5-(DIMETHYLAMINO)-2-HYDROXYBENZOYL]BENZOYL}AMINO)AZEPAN-3-YL]ISONICOTINAMIDE	A	1XH4	0.72
R69	N-[4-({4-[5-(DIMETHYLAMINO)-2-HYDROXYBENZOYL]BENZOYL}AMINO)AZEPAN-3-YL]ISONICOTINAMIDE	A	1XH9	0.72
826	1,3,4,9-TETRAHYDRO-2-(HYDROXYBENZOYL)-9-[(4-HYDROXYPHENYL)METHYL]-6-METHOXY-2H-PYRIDO[3,4-B]INDOLE	A,B	1I30	0.73
135	N-(4-CARBAMIMIDOYL-PHENYL)-2-HYDROXY-BENZAMIDE	B	1GJA	0.75
TI2	(2-SULFANYL-3-PHENYLPROPANOYL)-PHE-TYR	A	1QF0	0.72
L05	1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE	A,B,C,D,E,F,G,H	2ACL	0.76
CZP	(8R)-8-(CYCLOPENTYLMETHYL)-2-HYDROPEROXY-2-(4-HYDROXYBENZYL)-6-(4-HYDROXYPHENYL)-7,8-DIHYDROIMIDAZO[1,2-A]PYRAZIN-3(2H)-ONE	A,B	1UHH	0.71
968	2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID	A	1ONZ	0.72
3FT		A	2BXV	0.71
R94	N-(4-{[4-(2-HYDROXY-5-PIPERIDIN-1-YLBENZOYL)BENZOYL]AMINO}AZEPAN-3-YL)ISONICOTINAMIDE	A	1XH6	0.71
709	N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE	A	1ZSJ	0.78
TYP	CYCLO-(L-TYROSINE-L-PROLINE) INHIBITOR	A,B	1W1Y	0.71
CZN	(2S,8R)-8-BENZYL-2-HYDROPEROXY-6-(4-HYDROXYPHENYL)-2-(2-NAPHTHYLMETHYL)-7,8-DIHYDROIMIDAZO[1,2-A]PYRAZIN-3(2H)-ONE	A,B	1UHK	0.71
4BO	(3S)-3-amino-4-oxo-4-[(4-phenylmethoxyphenyl)amino]butanoic acid	A	3CHP	0.7
OI1	3-(4-HYDROXYBENZYL)-2-[1-({[2-(4-HYDROXYPHENYL)ETHYL]AMINO}CARBONYL)BUTYL]-4-OXO-3,6,11,11A-TETRAHYDRO-4H-PYRAZINO[1,2-B]ISOQUINOLIN-2-IUM-1-OLATE	A,B	1Q9D	0.75
YTT	(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione	A	3G5H	0.75
012	(4S)-N-[(1S,2R)-1-benzyl-3-{[3-(dimethylamino)benzyl]amino}-2-hydroxypropyl]-1-(3-methoxybenzyl)-2-oxoimidazolidine-4-carboxamide	A,B,C	3CKP	0.73
989	2-{[4-(2-ACETYLAMINO-2-PENTYLCARBAMOYL-ETHYL)-NAPHTHALEN-1-YL]-OXALYL-AMINO}-BENZOIC ACID	A	1NL9	0.72
CZH	C2-HYDROPEROXY-COELENTERAZINE	A	1QV1	0.72
CZH	C2-HYDROPEROXY-COELENTERAZINE	A	1JF2	0.72
CZH	C2-HYDROPEROXY-COELENTERAZINE	A	1SL9	0.72
CZH	C2-HYDROPEROXY-COELENTERAZINE	A	1JF0	0.72
CZH	C2-HYDROPEROXY-COELENTERAZINE	A	1QV0	0.72
CZH	C2-HYDROPEROXY-COELENTERAZINE	A,B	1EJ3	0.72
LI7	(3E)-3-[(4-HYDROXYPHENYL)IMINO]-1H-INDOL-2(3H)-ONE	A	1YXX	0.8
FEN	N-(4-HYDROXYPHENYL)ALL-TRANS RETINAMIDE	A	1FEL	0.72
MIX	1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE	A,B,C,D	2FUM	0.7
UA1	N-(TERT-BUTOXYCARBONYL)-L-TYROSYL-N-METHYL-4-(SULFOAMINO)-L-PHENYLALANINAMIDE	A	2I4H	0.76
UA1	N-(TERT-BUTOXYCARBONYL)-L-TYROSYL-N-METHYL-4-(SULFOAMINO)-L-PHENYLALANINAMIDE	A	2I4G	0.76
IOK	N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE	A,B	2IOK	0.76
GAH	N-{[(2S)-1-(N-{[4-({[AMINO(IMINO)METHYL]AMINO}METHYL)CYCLOHEXYL]CARBONYL}-3-CYCLOHEXYL-L-ALANYL)AZETIDIN-2-YL]CARBONYL}-L-TYROSYL-N~6~-[AMINO(IMINO)METHYL]-L-LYSINAMIDE	A,H	1XM1	0.7
541	(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE	A,B	2FV5	0.71
380	(2R)-2-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO)-N-BENZYL-2-(3,4-DIMETHOXYPHENYL)ACETAMIDE	H,L	1W2K	0.76
843	N-ACETYL-N-[1-(1,1'-BIPHENYL-4-YLMETHYL)-2-OXOAZEPAN-3-YL]-O-PHOSPHONOTYROSINAMIDE	A	1O42	0.74
I25	(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){3-[3-(DIMETHYLAMINO)-2,2-DIMETHYLPROPOXY]-5-ETHYLPHENYL}ACETIC ACID	H,I	2V3H	0.71